Journal Home
Search for

Volume 46, Issue 4, Pages 354-359 (December 2009)


View previous. 13 of 25 View next.

Hepatitis B precore/core promoter mutations in isolates from HBV-monoinfected and HBV–HIV coinfected patients: A 3-yr prospective study

Lucila Cassinoad, Natalia Lauferab, Horacio Salomonad, Rodolfo Camposcd, Jorge QuarleriadCorresponding Author Informationemail address

Received 11 August 2009; accepted 9 September 2009. published online 05 October 2009.

Abstract 

Background

The course of chronic HBV infection is modified by HIV-coexistence.

Objective

To analyze the role of HBV genomic heterogeneity in basal core promoter (BCP) and precore (Pc) genomic regions.

Study design

In a 3-yr prospective study, 39 HBV infected patients (20 monoinfected and 19 HIV-coinfected) were included. Eighty-two HBV isolates were studied at quasispecies level in the BCP/Pc genomic region. Clinical records obtained include data on lamivudine therapy and resistance mutations, HBV and HIV-viral load.

Results

HBV isolates were predominantly ascribed to genotype (Gt) A2 among HBV-monoinfected and HIV-coinfected patients. BCP mutations in isolates from monoinfected patients were significantly more frequent than in those from coinfected ones, irrespective of the HBe expression pattern (p<0.0001).

Regardless of the HIV-coexistence, the Pc mutation at G1896A only barely appeared among clone-derived sequences of GtF1 isolates, mainly from HBe(−) HBV-monoinfected patients.

Conclusions

HBV isolates characterized from HIV-coinfected patients seem to be more prone to exhibit a wild type genomic pattern at BCP regulatory region with respect to those from HBV-monoinfected ones. Besides, mutations at Pc region might be genotype-dependent in their frequency but not on HIV co-presence related.

a Centro Nacional de Referencia para el SIDA, Dto. Microbiología, Facultad de Medicina, Universidad de Buenos Aires, Argentina

b División de Enfermedades Infecciosas, Hospital Fernández, Buenos Aires, Argentina

c Cátedra de Virología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Argentina

d Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Argentina

Corresponding Author InformationCorresponding author at: Centro Nacional de Referencia para el SIDA, Paraguay 2155-Piso 11, 1121 Buenos Aires, Argentina. Tel.: +54 11 4508 3689; fax: +54 11 4508 3705.

 Sources of support: This work was partly supported by grants from Universidad de Buenos Aires (UBA; M431), and Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET, PIP6116).

PII: S1386-6532(09)00431-4

doi:10.1016/j.jcv.2009.09.015


View previous. 13 of 25 View next.